Labcorp closes Personal Genome Diagnostics purchase

LabPulse.com staff writers
Feb 22, 2022
2020 09 08 18 51 2374 Business Handshake Meeting 400

Labcorp has completed its purchase of cancer genomics firm Personal Genome Diagnostics.

The addition of Personal Genome Diagnostics to Labcorp's roster complements its existing liquid biopsy offerings and expands its oncology portfolio of next-generation sequencing (NGS)-based genomic profiling, it said.

The deal closed on December 23, 2021.

Latest in Sequencing
Test Tubes Social
Mission Bio launches new features for Tapestri platform
April 24, 2024
Labcorp Rtp 10 Med Res 950h 6x4 Social
Labcorp expands precision oncology offerings
April 12, 2024
Visit our Molecular Diagnostics Community
Sponsored
Visit our Molecular Diagnostics Community
April 5, 2024
Genome Sequence Barcode Social
Curio Bioscience to offer single-cell spatial mapping kit
March 19, 2024
Related Stories
Business Men Handshake Social
Mergers & Acquisitions
Genomics AI firm Genomenon acquires Boston Genetics
2022 07 19 20 21 8256 Clinical Trial Data Network 400
Collaboration
Labcorp expands European test kit production line
2020 06 01 18 51 2022 Cancer Lung 400
Sequencing
Labcorp to provide genomic profiling via sponsored program
Visit our Molecular Diagnostics Community
Sponsor Content
Visit our Molecular Diagnostics Community
More in Sequencing
Mission Bio launches new features for Tapestri platform
By Matt Limb
Mission Bio has launched new multiplexing features for its Tapestri platform, saying they will make single-cell technology more affordable and accessible to the biomedical community.
April 24, 2024
Test Tubes Social
Labcorp expands precision oncology offerings
By Matt Limb
Laboratory services firm Labcorp has announced the expansion of its precision oncology portfolio, aimed at supporting clinical research and advancing drug development programs.
April 12, 2024
Labcorp Rtp 10 Med Res 950h 6x4 Social
Oxford Nanopore, SeqOne to collaborate on sequencing platform
By LabPulse.com staff writers
Oxford Nanopore and genomics firm SeqOne are collaborating on an end-to-end platform for whole-genome nanopore sequencing reads for clinical diagnostic testing.
March 18, 2024
Dna Sequencing Data Analysis Social
Curio Bioscience to offer single-cell spatial mapping kit
By Matt Limb
Curio Bioscience is offering researchers early access to a product which it claims is the first in the world to transform single-cell genomics data into spatial context.
March 19, 2024
Genome Sequence Barcode Social
NGeneBio, Genolution to collaborate on automated NGS system
By LabPulse.com staff writers
Precision diagnostics company NGeneBio and molecular diagnostics firm Genolution have signed a memorandum of understanding to develop and launch an automated next-generation sequencing (NGS) system.
March 14, 2024
Business Handshake Intelligence Social
Twist Bioscience, Element Biosciences to collaborate on exome workflow
By LabPulse.com staff writers
Synthetic biology and genomics company Twist Bioscience and life science firm Element Biosciences have announced a collaboration to develop a dedicated workflow for Element’s AVITI system.
February 6, 2024
Test Tubes Social
U.K. Health Security Agency unveils five-year pathogen genomics strategy
By Matt Limb
The U.K. Health Security Agency (UKHSA) has unveiled a five-year plan to make pathogen genomics central to protecting public health and combating infectious disease threats.
February 1, 2024
Lab Microscope Slide Social
Study uncovers role of genetic variants in blood cancer development
By Matt Limb
Scientists have used large scale data analysis to investigate why only some people with a common mutation go on to develop rare blood cancer.
January 23, 2024
Lab Blood Centrifuge Social
Thermo Fisher goes big with new pangenome array
By LabPulse.com staff writers
Thermo Fisher Scientific announced the launch of a new human genomics research tool that complements the recent development of the pangenome.
January 5, 2024
Genome Sequence Barcode Social
Heated legal battles continue in cell-free DNA testing market
By Liz Carey
Clinical genetic testing manufacturer Natera announced another victory in its fight to stop other companies from capitalizing on cell-free DNA (cfDNA) testing that appears to infringe on its patents. More genetic testing patent disputes are pending.
January 2, 2024
Lawsuit Social
UK Biobank shares 500K WGS linked to 15 years of health data
By Nick Paul Taylor
UK Biobank has made deidentified whole genome sequencing (WGS) data on 500,000 people available, enabling researchers around the world to analyze the genomics results alongside 15 years of health data on the individuals.
December 4, 2023
Science Genome Sequence Dna Map Social
Nanopore sequencing slashes tumor analysis times and costs
By Nick Paul Taylor
Nanopore sequencing makes the analysis of copy number variations (CNVs) faster, cheaper, and simpler, according to a preprint paper from researchers at Dartmouth-Hitchcock Medical Center.
November 28, 2023
Dna Sequence Social
Page 1 of 49
Next Page